Cargando…
Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series Vaccine in Pediatric Patients with Predominant Antibody Deficiency
Autores principales: | Tandon, Megha, DiGiacomo, Daniel, Rosenberg, Chen, Hesterberg, Paul, Barmettler, Sara, Farmer, Jocelyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895879/ http://dx.doi.org/10.1016/j.jaci.2022.12.613 |
Ejemplares similares
-
Response to SARS-CoV-2 initial series and additional dose vaccine in pediatric patients with predominantly antibody deficiency
por: Tandon, Megha, et al.
Publicado: (2023) -
Kinetics of Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Doses in Patients With Predominant Antibody Deficiency
por: DiGiacomo, Daniel, et al.
Publicado: (2023) -
Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series and Additional Dose Vaccine in Patients With Predominant Antibody Deficiency
por: Barmettler, Sara, et al.
Publicado: (2022) -
Predominant Antibody Deficiency and Risk of Microscopic Colitis: a Nationwide Case–Control Study in Sweden
por: DiGiacomo, Daniel V., et al.
Publicado: (2023) -
Antibody Response to SARS CoV-2 Immunization in Patients with Immunodeficiency
por: DiGiacomo, Daniel, et al.
Publicado: (2022)